FDA approves landmark pancreatic cancer drug

The FDA has approved a groundbreaking new pancreatic cancer drug that represents a significant advancement in treatment options for this deadly disease. The medication works by blocking a protein that drives tumor growth in most pancreatic cancer cases, offering patients improved survival outcomes through a novel therapeutic approach.